Aardvark Therapeutics (AARD) Selling, General & Administrative (2024 - 2026)
Aardvark Therapeutics (AARD) posted Selling, General & Administrative of $4.63 million for Q2 2026, up 71.3% from $2.7 million a year earlier but down 21.5% from the prior quarter.
Powered by 
Analysis
Aardvark Therapeutics (AARD) Selling, General & Administrative (2024 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Aardvark Therapeutics was $18.9 million, up 141.3% year-over-year; for FY2025, it came in at $13.79 million, up 159.9% from FY2024.
- In prior years, Aardvark Therapeutics' Selling, General & Administrative was $5.31 million in FY2024.
- Quarterly Selling, General & Administrative has run from a low of $861,000 in Q1 2024 to a high of $5.9 million in Q1 2026 over five years.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last six quarters, with growth averaging 156.8% over the last six quarters.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $5.9 million (Q1 2026), $4.41 million (Q4 2025) and $3.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Aardvark Therapeutics | 115.33 Mn | 41.43 Mn | - | 4.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.63 Mn |
| Mar 31, 2026 | 5.90 Mn |
| Dec 31, 2025 | 4.41 Mn |
| Sep 30, 2025 | 3.97 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 861,000.00 |
API Access
Aardvark Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AARD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "AARD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AARD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();